BFS
AGN

Bradley Foster & Sargent’s Allergan Inc AGN Stock Holding History

Bradley Foster & Sargent’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,210
Closed -$205K – 370
2014
Q2 		$205K Buy
+1,210
New +$188K 0.01% 332

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bradley Foster & Sargent's AGN Position: Q3 2014 in Review

Bradley Foster & Sargent sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 1,210 shares — an estimated $205K sold.

Bradley Foster & Sargent first reported a position in AGN in Q2 2014 and held it in 1 quarter. The position peaked at $205K in Q2 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Bradley Foster & Sargent reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • Bradley Foster & Sargent sold 1,210 Allergan Inc shares in Q3 2014, an estimated $205K.
  • Bradley Foster & Sargent first reported a position in Allergan Inc in Q2 2014 and held it in 1 quarter.
  • Bradley Foster & Sargent's Allergan Inc position peaked at $205K in Q2 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Bradley Foster & Sargent's 13F filing for Q3 2014, filed 7 Nov 2014.